Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species

被引：0
|
作者：
Tabebordbar, S. [1 ]
Lagerborg, K. [2 ]
Ye, S. [2 ]
Stanton, A. [2 ]
King, E. [2 ]
Tellez, L. [2 ]
Krunnfusz, A. [2 ]
Tavakoli, S. [3 ]
Widrick, J. [4 ]
Messemer, K. [3 ]
Troiano, E. [4 ]
Moghadaszadeh, B. [4 ]
Peacker, B. [3 ]
Leacock, K. [3 ]
Horwitz, N. [3 ]
Beggs, A. [4 ]
Wagers, A. [3 ]
Sabeti, P. [2 ]
机构：
[1] Kate Therapeut, San Diego, CA USA
[2] Broad Inst, Cambridge, MA USA
[3] Harvard Univ, Cambridge, MA 02138 USA
[4] Boston Childrens Hosp, Boston, MA USA
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.225
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
I.11
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [1] Directed evolution of a family of AAV capsid variants enabling potent muscle-directed gene delivery across species
    Tabebordbar, Mohammadsharif
    Lagerborg, Kim A.
    Stanton, Alexandra
    King, Emily M.
    Ye, Simon
    Tellez, Liana
    Krunnfusz, Allison
    Tavakoli, Sahar
    Widrick, Jeffrey J.
    Messemer, Kathleen A.
    Troiano, Emily C.
    Moghadaszadeh, Behzad
    Peacker, Bryan L.
    Leacock, Krystynne A.
    Horwitz, Naftali
    Beggs, Alan H.
    Wagers, Amy J.
    Sabeti, Pardis C.
    CELL, 2021, 184 (19) : 4919 - +
  • [2] Novel AAV capsid variant for muscle-directed gene therapy
    Lemoine, J.
    Just, S.
    Dominguez, N.
    Galy, A.
    Buening, N.
    Richard, I.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A29 - A29
  • [3] Directed Evolution of Adeno-Associated Virus Variants Enabling Potent Gene Delivery for the Treatment of Osteoarthritis
    Kim, Y. J.
    Ji, E. H.
    Joo, K. I.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A106 - A106
  • [4] Directed evolution of AAV2 yields novel capsid variants
    Maheshri, N
    Kaspar, B
    Schaffer, DV
    MOLECULAR THERAPY, 2004, 9 : S8 - S8
  • [5] MyoScreen™, a discovery platform for candidate selection of muscle-directed AAV gene therapies
    Votteler, J.
    Le Guiner, C.
    Webb, S.
    Young, J.
    Duchemin-Pelletier, E.
    Lorintiu, O.
    Bourdon, A.
    Hammond, S.
    Tretiakova, A.
    Samulski, R. J.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A254 - A255
  • [6] Antibody Conjugated AAV Vectors for Efficient and Specific Skeletal Muscle Directed Gene Delivery across Species
    Samai, Poulami
    Stec, Michael
    Le Rouzic, Valerie
    Khan, Naveen
    Golann, David
    Jose, Clarisse Lou
    Cherravuru, Samvitha
    Tareen, Ammar
    Sleeman, Mark
    Moller-Tank, Sven H.
    Kyratsous, Christos
    Sabin, Leah
    MOLECULAR THERAPY, 2023, 31 (04) : 22 - 23
  • [7] Capsid-Modified Adenoviral Vectors for Improved Muscle-Directed Gene Therapy
    Guse, Kilian
    Suzuki, Masataka
    Sule, Gautam
    Bertin, Terry K.
    Tyynismaa, Henna
    Ahola-Erkkila, Sofia
    Palmer, Donna
    Suomalainen, Anu
    Ng, Philip
    Cerullo, Vincenzo
    Hemminki, Akseli
    Lee, Brendan
    HUMAN GENE THERAPY, 2012, 23 (10) : 1065 - 1070
  • [8] NGS and Bioinformatics Pipeline for Targeted AAV Delivery by Directed Capsid Evolution
    Marsic, Damien
    Boye, Sanford L.
    Boye, Shannon E.
    Zolotukhin, Sergei
    MOLECULAR THERAPY, 2017, 25 (05) : 260 - 260
  • [9] Muscle-directed gene therapy for phenylketonuria with self-complementary AAV vectors
    Kume, A.
    Yagi, H.
    Mizukami, H.
    Urabe, M.
    Tsukahara, T.
    Uchibori, R.
    Ozawa, K.
    HUMAN GENE THERAPY, 2011, 22 (10) : A49 - A50
  • [10] Directed evolution of AAV mutants for enhanced gene delivery
    Schaffer, DV
    Maheshri, N
    PROCEEDINGS OF THE 26TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7, 2004, 26 : 3520 - 3523
12345